Vitiligo therapy

Bibliography

• Huggins RH, Schwartz RA, Janniger CK. Childhood vitiligo. Cutis 2007;79:277-80
   PubMed Web of Science ®Google Scholar
• Lotti T, Gori A, Zanieri F, Vitiligo: new and emerging treatments. Dermatol Ther 2008;21:110-7
   PubMed Web of Science ®Google Scholar
• Hu Z, Liu JB, Ma SS, Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol 2006;23:114-16
   PubMed Web of Science ®Google Scholar
• Iacovelli P, Sinagra JL, Vidolin AP. Relevance of thryroiditis and other autoimmune diseases in children with vitiligo. Dermatology 2005;210:26-30
   PubMed Web of Science ®Google Scholar
• Pajvani U, Ahmad N, Wiley A, The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol 2006;55:238-44
   PubMed Web of Science ®Google Scholar
• Van der Wijngaard RM, Aten J, Sheepmaker A, Expression and modulation of apoptosis regulatory molecules in human melanocyte: significance in vitiligo. Br J Dermatol 2000;143:573-81
   PubMed Web of Science ®Google Scholar
• Lotti T, Prignano F, Buggiani G. New and experimental treatments of vitiligo and other hypomelanoses. Dermatol Clin 2007;25:393-400, (review of different therapeutical modalities)
   PubMed Web of Science ®Google Scholar
• Whitton ME, Ashcroft DM, Gonzales U. Therapetic interventions for vitiligo. J. Am Acad Dermatol 2008;59:713-7
   PubMed Web of Science ®Google Scholar
• Hirobe T. The role of keratinocytes derived factors involved in the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005;18:2-12
   PubMedGoogle Scholar
• Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo in UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-8
   PubMed Web of Science ®Google Scholar
• Jones SS, Palmer RA; Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol 2007;143(5):578-84
   PubMedGoogle Scholar
• Njoo MD, Bos JD, Westerhof W. Treatment generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000;42:245-53
   PubMed Web of Science ®Google Scholar
• Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 2005;30:332-6
   PubMed Web of Science ®Google Scholar
• Kunisada M, Kumimoto H, Ishizaki K, Narrow-Band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J Invest Dermatol 2007;127:2865-71
   PubMed Web of Science ®Google Scholar
• Menchini G, Tsoureli-Nikita E, Hercogova. Narrowband UV-B microphototherapy: a new treatment of vitiligo. J Eur Acad Dermatol Venereol 2003;17:171-7
   PubMed Web of Science ®Google Scholar
• Martin JA, Laube S, Edwards C, Rate of acute adverse events for narrow-band UVB and psoralen-UVA phototherapy. Photodermatol Photoimmunol Photomed 2007;23:68-72
   PubMed Web of Science ®Google Scholar
• Lotti T, Buggiani G, Troiano M, Targeted and combination treatments for vitiligo. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol Ther 2008;21:S20-6
   PubMed Web of Science ®Google Scholar
• Lotti T, Rossi R, Campolmi P. Targeted UV-B phototherapy: when and why to start. Arch Dermatol 2006;142:933-4
   PubMedGoogle Scholar
• Hercogova J, Buggiani G, Prignano F, Lotti T. A rational approach to the treatment of vitiligo and other hypomelanoses. Dermatol Clin 2007;25:383-92
   PubMed Web of Science ®Google Scholar
• Esposito M, Soda R, Costanzo A, Cimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004;29:133-7
   PubMed Web of Science ®Google Scholar
• Passeron T, Ortonne JP. Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin Dermatol 2006;24:33-42
   PubMed Web of Science ®Google Scholar
• Passeron T, Ortonne JP. The 308 nm excimer laser in dermatology. Presse Med 2005;34:301-9
   PubMed Web of Science ®Google Scholar
• Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol 2003;17:531-7
   PubMed Web of Science ®Google Scholar
• Chimento SM, Newland M, Ricotti C, A pilot study to determine the safety and the efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol 2008;7:258-63
   PubMed Web of Science ®Google Scholar
• Kollner K, Wimmershoff MB, Hintz C, Comaprison of 308-nm excimer laser and 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the ttreatment of psoriasis. Br J Dermatol 2005;152:750-4
   PubMed Web of Science ®Google Scholar
• Yu HS, Wu CS, Yu CL, Helium-neon laser irratiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J Invest Dermatol 2003;120:56-64
   PubMed Web of Science ®Google Scholar
• Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Paired comparison study on narrow band (TL-01) UVB phototherapy versus photochemotherapy (PUVA) in the treatment of chronic plaque type psoriasis. Arch Dermatol 1999;135:519-24
   PubMedGoogle Scholar
• Mai DW, Omohundro C, Dijkstra JW, Bailin PL. Childhood vitiligo successfully treated with bath PUVA. Pediatr Dermatol 1998;15:53-5
   PubMed Web of Science ®Google Scholar
• Forschner T, Buchholtz S, Stockfleth E. Current state of vitiligo therapy – evidence-based analysis of the literature. J Dtsch Dermatol Ges 2007;5:467-75
   PubMedGoogle Scholar
• Kwinter J, Pelletier J, Khambalia A, Pope E. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol 2007;56:236-41
   PubMed Web of Science ®Google Scholar
• Grimes PEMorris S, Avaniss-Aghajani E, Soriano T, Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004;51:52-61
   PubMed Web of Science ®Google Scholar
• Passeron T, Ostovari N, Zakaria W, Topical tacrolimus and the 308 nm excimer laser. A synergistic combination for treatment of vitiligo. Arch Dermatol 2004;140:1065-9
   PubMed Web of Science ®Google Scholar
• Hartmann A, Brocker EB, Hamm H. Occlusive treatment enhances the efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study Acta Derm. Venereol 2008;88:474-9
   Google Scholar
• Berti S, Buggiani G, Lotti T. Use of tacrolimus ointment in vitiligo alone or in combination therapy. Skin Ther Lett 2009;4:5-7
   Google Scholar
• Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1% cream plus narrow-band nultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatol Treat 2008;16:1-5
   Google Scholar
• Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol 2004;21:495-8
   PubMed Web of Science ®Google Scholar
• Leone G, Pacifico A. Profile of clinical efficay and safety of topical tacalcitol. Acta Biomed 2005;76:13-9
   PubMedGoogle Scholar
• Gargoom AM, Duweb GA, Elzorghany AH, Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res 2004;24:11-4
   PubMedGoogle Scholar
• Kieffer MA. Topical vitamin D analogs. Dermatol Nurs 2004;16:89-90
   PubMedGoogle Scholar
• Rodriguez-Martin M, Gartcia Bustinduy M, Saez Rodriguez M, Nola Cabrera A. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. Br J Dermatol 2009;!60:409-14
   Google Scholar
• Leone G, Pacifico A, Iacovelli P, Tacacitol and narrow-band phototherapy in patients with vitiligo. Clin Exp Dermatol 2006;31:200-5
   PubMed Web of Science ®Google Scholar
• Lu-yan T, Wen-wen F, Lei-hong X, Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2006;22:310-4
   PubMed Web of Science ®Google Scholar
• Parsad P, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol 2004;50:63-7
   PubMed Web of Science ®Google Scholar
• Baysal W, Yildirim M Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol 2004;17:299-302
   Web of Science ®Google Scholar
• Hasse S, Gibbons NC, Rokos H, Perturbed 6-tetrahydrobiopterin recycling via decreased dihydrobiopteridine reductase in vitiligo: more evidence for H2O2 stress. J Invest Dermatol 2004;122:307-13
   PubMed Web of Science ®Google Scholar
• Schallreuter KU. Effectiveness of pseudocatalase formulations in vitiligo. Clin Exp Dermatol 2003;28:562-3
   PubMed Web of Science ®Google Scholar
• Khemis A, Ortonne JP. Etude comparative d’un extrait vegetal possedand une activité superoxide dismutase (VITIX®) plus phototherapie UVB selective versus son excipient plus phototherapie selective dans le traitment du vitiligo vulgaire. Nouvelle Dermatologique 2004;23:7-11
   Google Scholar
• Spencer JD, Gibbons NCJ, Rokos H, Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 2007;127:411-20
   PubMed Web of Science ®Google Scholar
• Dell’Anna ML, Mastrofrancesco A, Sala R, Antioxidants and narrow band UVB in the treatment of vitiligo: a double blind placebo controlled trial. Clin Exp Dermatol 2007;32:631-6
   PubMed Web of Science ®Google Scholar
• Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: a randomized trial double-blind placebo-controlled study. J Eur Dermatol Venereol 2007;21:942-50
   PubMed Web of Science ®Google Scholar
• Parsad D, Pandhi R, Dogra S, Kumas B. Topical prostaglandin analog (PGE2) in vitiligo: preliminary study. Int J Dermatol 2002;41:942-5
   PubMed Web of Science ®Google Scholar
• Wakke M, Assen YJ, Thio HB, Neumann AM. Repigmentation of vitiligo during efalizumab. J Am Acad Dermatol 2008;59:S57-8
   PubMed Web of Science ®Google Scholar
• Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with 4-methoxyphenol and Q-switched ruby laser. J Am Acad Dermatol 2000;42:760-9
   PubMed Web of Science ®Google Scholar
• Radmanesh M. Depigmentation of the normally pigmented patches in universal vitiligo patients with cryotherapy. J Eur Acad Dermatol 2000;14:149-52
   Web of Science ®Google Scholar
• Chen YF, Yang PY, Hu DN, Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J Am Acad Dermatol 2004;51:68-74
   PubMed Web of Science ®Google Scholar
• Rusfianti M, Wirohadidjodjo YW. Dermosurgical techniques for repigmentation of vitiligo. Dermatol Surg 2006;32:387-91
   PubMed Web of Science ®Google Scholar
• Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol 2003;49:99-104
   PubMed Web of Science ®Google Scholar
• Leachman S. Surgical therapies. Part III. Melanocyte transplants. Dermatol Ther 2001;14:20-8
   Google Scholar
• Pianigiani E, Andreassi A, Andreassi L. Autografts and cultured epidermis in the treatment of vitiligo. Clin Dermatol 2005;23:424-9
   PubMed Web of Science ®Google Scholar
• Andreassi A, Pianigiani E, Taddeucci P, Tissue-engineered skin in the treatment of vitiligo lesions. In: Lotti T, Hercogova J, editors, Vitiligo: problems and solutions Marcel Dekker, Inc, New York, USA; 2004. p. 313-21
   Google Scholar